FIXX Insider Trading Activity and SEC Form 4 Filings
FIXX insider trading summary
No open-market insider purchases or sales of Homology Medicines, Inc. (FIXX) have been reported on SEC Form 4 in the past 12 months.
Latest FIXX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 9, 2024 | Arthur Tzianabos | Insider | Sell | $7K (13,037 @ $0.57) |
| Jan 3, 2024 | Charles Michaud Jr | See Remarks | Sell | $975 (1,708 @ $0.57) |
| Jan 3, 2024 | Paul Alloway | See Remarks | Sell | $4K (7,280 @ $0.57) |
| Sep 6, 2023 | Albert Seymour | See Remarks | Sell | $2K (1,448 @ $1.15) |
| Aug 3, 2023 | Julie Jordan | Chief Medical Officer | Sell | $2K (1,308 @ $1.39) |
| Aug 3, 2023 | Julie Jordan | Chief Medical Officer | Sell | $606 (436 @ $1.39) |
| Aug 3, 2023 | Julie Jordan | Chief Medical Officer | Sell | $152 (109 @ $1.39) |
| Aug 2, 2023 | Julie Jordan | Chief Medical Officer | Sell | $130 (99 @ $1.31) |
| Mar 2, 2023 | Paul Alloway | See Remarks | Sell | $16K (10,965 @ $1.45) |
| Jan 9, 2023 | Arthur Tzianabos | Director | Sell | $15K (10,616 @ $1.39) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.